换一批Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients.
第一作者：
I,Zlobec
第一单位：
Institute for Pathology, University Hospital of Basel, 4031 Basel, Switzerland. izlobec@uhbs.ch
作者：
主题词
腺癌(Adenocarcinoma);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);结直肠肿瘤(Colorectal Neoplasms);结直肠肿瘤, 遗传性非息肉性(Colorectal Neoplasms, Hereditary Nonpolyposis);女(雌)性(Female);随访研究(Follow-Up Studies);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因, ras(Genes, ras);人类(Humans);男(雄)性(Male);中年人(Middle Aged);丝裂原激活蛋白激酶激酶类(Mitogen-Activated Protein Kinase Kinases);观察者偏差(Observer Variation);试验预期值(Predictive Value of Tests);预后(Prognosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);随机分配(Random Allocation);结果可重复性(Reproducibility of Results);信号传导(Signal Transduction)
DOI
10.1038/sj.bjc.6605452
PMID
19935791
发布时间
2021-12-03
- 浏览28
British journal of cancer
151-61页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
